(Q48680186)

14 February 2018

title

Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

28 August 2023

0 references

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

28 August 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

28 August 2023

4

Linnoila M

1 reference

14 February 2018

author name string

N. A. Garrick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6203542

28 August 2023

M. Scheinin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6203542

28 August 2023

W. H. Chang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6203542

28 August 2023

D. L. Murphy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6203542

28 August 2023

language of work or name

English

0 references

publication date

1 May 1984

1 reference

14 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0006295284904088?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

https://api.elsevier.com/content/article/PII:0006295284904088?httpAccept=text/plain

28 August 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

28 August 2023

published in

Biochemical Pharmacology

1 reference

14 February 2018

volume

33

1 reference

14 February 2018

issue

9

1 reference

14 February 2018

page(s)

1423-1427

1 reference

14 February 2018

Comparative Trial of a New Mono-Amine Oxidase Inhibitor in Depression

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Comparative behavioral effects of clorgyline and pargyline in man: A preliminary evaluation

28 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Multiple binding sites of human brain and liver monoamine oxidase: substrate specificities, selective inhibitions, and attempts to separate enzyme forms

28 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Dopamine is a monoamine oxidase B substrate in man.

28 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain

28 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin.

28 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation

28 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain

28 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Effect of Low-Dose Clorgyline on 24-Hour Urinary Monoamine Excretion in Patients With Rapidly Cycling Bipolar Affective Disorder

28 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

The central noradrenergic system and affective response to MAO inhibitors

28 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid

28 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man

28 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection

28 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Brain amine concentrations after monoamine oxidase inhibitor administration.

28 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Substrate-selective monoamine oxidases—inhibitor, tissue, species and functional differences

28 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Tele-Methylhistamine is a specific MAO B substrate in man

28 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain

28 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Type A monoamine oxidase catalyzes the intraneuronal deamination of dopamine within nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons in the rat

28 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme type

28 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

3HHarmaline as a specific ligand of MAO A--I. Properties of the active site of MAO A from rat and bovine brains

28 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Turnover rates of serotonin and norepinephrine in brain of normal and pargyline-treated rats

28 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Chronic effects of a monoamine oxidase-inhibiting antidepressant: decreases in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3': 5'-monophosphate systems in rat brain.

28 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations

28 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

Cumulative effects of irreversible MAO inhibitors in vivo

28 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0006-2952(84)90408-8

28 August 2023

Identifiers

1 reference

14 February 2018

1 reference

14 February 2018